Journal of Antimicrobial Chemotherapy, Vol 39, 63-66, Copyright © 1997 by The British Society for Antimicrobial Chemotherapy
V Lorian and F Fernandes
Clinical specimens were cultured, and the strains identified by the Vitek
system as Enterococcus faecium were characterized by their DNA. The MIC
vancomycin, quinupristin/dalfopristin and teicoplanin for each isolate was
determined. Ten vancomycin-sensitive and ten vancomycin- resistant strains
of E. faecium were tested. Quinupristin/dalfopristin at 0.25 x MIC and
vancomycin at 0.5 x MIC separately as well as in combination were added to
Trypticase Soy Broth tubes inoculated with a 24 h culture. The results
obtained by determining cfu at 2, 4, 8, 12 and 24 h indicated that the
combination of subinhibitory concentrations of quinupristin/dalfopristin
plus vancomycin produced after 24 h, in vancomycin-resistant strains, a
consistent degree of synergy. Synergy was observed up to only 12 h when
similar combinations were employed for vancomycin-sensitive strains.
Vancomycin-sensitive strains tended to be slightly less susceptible to
quinupristin/dalfopristin than vancomycin-resistant strains.
ORIGINAL ARTICLES
Synergic activity of vancomycin-quinupristin/dalfopristin combination against Enterococcus faecium
Bronx Lebanon Hospital Center, NY 10457, USA.
![]()
CiteULike
Connotea
Del.icio.us What's this?